First biosimilar of infliximab approved in Brazil: response from the Brazilian IBD society

Author(s): Professor Fabio V Teixeira, MSc, MD, PhD

Abstract: CT-P13 was the first infliximab biosimilar approved in Brazil. Approval was granted for all indications of the innovator. Despite similar efficacy and safety, vigilance remains essential. Submitted: 4 January 2016; Revised: 27 January 2016; Accepted: 1 February 2016; Published online first: 12 February 2016 On 27 April 2015, the Brazilian Health Surveillance Agency (Agência […]

Read more →